title: A run-in period is needed in randomized controlled trials of directly observed antiretroviral therapy for HIV infection.
authors.affiliation: *The HIV Epidemiology and Field Services Program, Bureau of HIV Prevention and Control, New York City Department of Health and Hygiene, New York, NY †The Division of HIV Prevention and Control, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
authors.forename: Qiang
authors.initials: Q
authors.lastname: Xia
authors.forename: Zhen
authors.initials: Z
authors.lastname: Ning
authors.forename: Lucia V
authors.initials: LV
authors.lastname: Torian
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D023801:Directly Observed Therapy / Q000379:methods*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D044966:Anti-Retroviral Agents